India?s Lupin looks to revive U.S. growth with $880 million GAVIS deal
 

India?s Lupin looks to revive U.S. growth with $880 million GAVIS deal
MUMBAI (Reuters) - Lupin Ltd , India's third-largest drugmaker by sales, is buying U.S. peer GAVIS Pharmaceuticals LLC for $880 million in its largest ever acquisition, seeking to revive its flagging...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...e8:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...e8:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/XEIMNG-N3Pc